Safety Assessment of Magnesium Sulfate as Used in Cosmetics

International Journal of Toxicology
Wilbur JohnsonBart Heldreth

Abstract

The Cosmetic Ingredient Review Expert Panel (Panel) reviewed the safety of magnesium sulfate, which functions as a bulking agent in cosmetic products and is reportedly used at concentrations up to 11% and 25% in leave-on and rinse-off products, respectively. The Panel noted that the history of safe medical use of magnesium sulfate provides further confidence that there are no significant toxicity concerns relating to systemic exposure to this ingredient after cosmetic product application. Furthermore, the extensive clinical experience of the Panel, including the results of numerous patch tests, indicates that magnesium salts do not have the potential to induce sensitization. The Panel also noted that results were negative for 50% magnesium sulfate in a mouse skin irritation study and in an in vitro sensitization assay. The Panel concluded that magnesium sulfate is safe in cosmetics in the present practices of use and concentration described in the safety assessment.

References

Jan 1, 1979·American Journal of Obstetrics and Gynecology·L C Chesley
Jan 1, 1992·Environmental and Molecular Mutagenesis·D A Pagano, E Zeiger
Oct 1, 1989·American Journal of Obstetrics and Gynecology·J M ThorpR C Cefalo
Dec 1, 1988·The Journal of Pediatrics·C I LammJ G Rabinowitz
Mar 21, 1968·The New England Journal of Medicine·W E Wacker, A F Parisi
Aug 1, 1984·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·M IshidateA Matsuoka
Apr 1, 1983·Journal of Toxicology. Clinical Toxicology·M E Morris, G Levy
Dec 1, 1981·Biulleten' eksperimental'noĭ biologii i meditsiny·G A Debova
Jul 1, 1994·Occupational and Environmental Medicine·H HoriI Tanaka
Jun 9, 1998·The Journal of Toxicological Sciences·M MochizukiK Shimamura
Jun 9, 1998·The Journal of Toxicological Sciences·K AkagiK Shimamura
Apr 28, 2000·Intensive Care Medicine·S J Fletcher, M J Parr
Jun 18, 2002·American Journal of Obstetrics and Gynecology·Robert MittendorfPaul G Tomich
May 23, 2009·Obstetrics and Gynecology·John P ElliottThomas J Garite
Jul 10, 2012·American Journal of Perinatology·Mina Abbassi-GhanavatiKenneth J Leveno

❮ Previous
Next ❯

Methods Mentioned

BETA
chromosomal aberrations
chromosomal aberration

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

International Journal of Toxicology
Wilbur JohnsonF Alan Andersen
International Journal of Toxicology
Wilbur JohnsonF Alan Andersen
International Journal of Toxicology
Wilbur JohnsonF Alan Andersen
International Journal of Toxicology
Lillian C BeckerF Alan Andersen
International Journal of Toxicology
Wilbur JohnsonF Alan Andersen
© 2022 Meta ULC. All rights reserved